Validating NanoTherm® Therapy and Building Confidence within the Medical Community

In the past decade MagForce was able to develop marketable products on the basis of an initial idea and first positive research data. However, the Company’s work in research and development is by no means done with the approval of the NanoTherm® therapy. MagForce strives to continuously improve its products in order to improve the treatment outcome of the therapy and at the same time reduce the burden on patients to a minimum degree. Our new post marketing clinical study has the objective to improve the acceptance of the NanoTherm® therapy in the medical community, to generate increased, profound knowledge and new data and to get market authorization for the therapy as therapeutic.

Since MagForce is currently focussing on the post marketing clinical trial, all other early research activities have temporarily been put on hold.